Literature DB >> 9781057

BRCA2 germline mutations in Swedish breast cancer families.

J Chen1, M Z Hedman, B W Arver, S Sigurdsson, J E Eyfjörd, A Lindblom.   

Abstract

Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781057     DOI: 10.1038/sj.ejhg.5200167

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Authors:  Sara Margolin; Hemming Johansson; Lars Erik Rutqvist; Annika Lindblom; Tommy Fornander
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

3.  Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India.

Authors:  Vani Syamala; Leelakumari Sreeja; Volga S Syamala; B Vinodkumar; Praveenkumar B Raveendran; Hariharan Sreedharan; Ratheesan Kuttappan; Lekshmi Balakrishnan; Ravindran Ankathil
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-15       Impact factor: 4.553

4.  Low frequency of E-cadherin alterations in familial breast cancer.

Authors:  S Salahshor; L Haixin; H Huo; V N Kristensen; N Loman; S Sjöberg-Margolin; A Borg ; A L Børresen-Dale; I Vorechovsky; A Lindblom
Journal:  Breast Cancer Res       Date:  2001-03-09       Impact factor: 6.466

5.  CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer.

Authors:  Sara Margolin; Hans Eiberg; Annika Lindblom; Marie Luise Bisgaard
Journal:  BMC Cancer       Date:  2007-08-17       Impact factor: 4.430

6.  A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.

Authors:  Xiao-Lei Zhou; Barbro Werelius; Annika Lindblom
Journal:  Breast Cancer Res       Date:  2004-03-09       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.